Sponsor Pipeline

Kind Pharmaceuticals LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
5
Recruiting
2
Phase 3
4
Disease Areas
Active Trials by Phase
Phase 3
2
Phase 2
4
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07487727 A Study of AND017 to Evaluate Efficacy and Safety in Patients With Anemia Due to… Anemia Due to Chronic Kidney Disease Recruiting
NCT07494409 A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney… Anemia Due to Chronic Kidney Disease Recruiting
Phase 2
NCT06302491 A Study of Safety and Efficiency of AND017 in Patients With β-thalassemia β -Thalassemia Recruiting
NCT06304103 A Study of Efficacy and Safety of AND017 in Patients With Myelodysplastic Syndrome Myelodysplastic Syndromes Recruiting
NCT06075030 A Study of AND017 in Cancer Related Anemic Patients Receiving Chemotherapy Chemotherapy Induced Anemia Not Yet Recruiting
NCT06075043 A Study of AND017 to Treat Cancer Related Anemia in Patients Not Receiving Chemotherapy Cancer-Related Anemia Not Yet Recruiting
Phase 1
NCT05187832 A Study of AND019 in Women With ER Positive HER2 Negative Advanced or Metastatic Breast… Advanced or Metastatic Breast Cancer Recruiting
Disease Areas
Get alerts when Kind Pharmaceuticals LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free